LifeNome Inc. Company
Overview
LifeNome is a leading precision health and longevity technology company that provides cutting-edge, science-backed solutions for enterprises in healthcare, wellness, insurance, and employee benefits. Powered by proprietary genomics, epigenetics, and biodata science, LifeNome’s flagship product, Longevity OS, enables organizations to offer highly personalized health and longevity insights to their end-users at scale.
With a founding team including multiple scholars ranked among the top 20 most-cited scientists globally in genomics and public health, LifeNome combines deep scientific expertise with an enterprise-ready platform designed for maximum interoperability and compliance (HIPAA, GDPR).
Team: LifeNome co-founders Raya Khanin (Weizman PhD, Royal Society Fellowship), Ali Mostashari (MIT PhD, 15 years in tech R&D), and Mario Storga (PhD, KTH, UofZ, Design Society) are each in the top 20 cited scholars in the world in their respective fields of computational genomics, complexity science, and semantic networks in the world. Team consists 30 individuals with 15 PhDs based in NYC and Europe.
Products and Services
Longevity OS:
A turnkey operating system for personalized longevity recommendations based on multi-omics data (genomics, epigenetics, biodata). Longevity OS powers longevity assessments, precision nutrition, personalized wellness, and preventive health programs across B2B channels.
Precision Health API Suite:
Modular APIs that allow companies to integrate genetics-based risk assessments, wellness optimization, nutrition personalization, and longevity insights into existing platforms.
Employee Wellness & Insurtech Solutions:
LifeNome’s enterprise-grade solutions support insurers and self-insured employers in reducing costs, improving employee well-being, and enhancing engagement through scientifically validated personalization.
Differentiators
Scientific Credibility: Founding and leadership team includes researchers cited among the world's top 0.01% in public health, epidemiology, and systems engineering.
Data Versatility: Ability to operate across biodata inputs, including wearable device data, blood tests, microbiome, epigenetic markers, and genetic reports.
Compliance-First: HIPAA, GDPR, and ISO27001 aligned systems.
B2B-Focused: Tailored for enterprise deployment with white-label options, API-first architecture, and support for custom longevity models.
Recent Highlights
Launch of Longevity OS (2024): An enterprise-first platform enabling corporations to deploy personalized longevity offerings with full customization and scalability.
Top 10 Precision Health Innovators (2024): Recognized by CB Insights as Outperformer in Precision Health among top 15 companies including Viome, Inside Tracker and others.
Strategic partnerships: M42, LG, Genetria, PEPSICO, Allergan and others.
